Antibody Information
General Information of This Antibody
Antibody ID | ANI0GDTIL |
|||||
---|---|---|---|---|---|---|
Antibody Name | Anti-PSMA mAb hD7-1 |
|||||
Antibody Type | Monoclonal antibody (mAb) |
|||||
Antibody Subtype | Humanized IgG |
|||||
Antigen Name | Glutamate carboxypeptidase 2 (FOLH1) |
Antigen Info |
Each Antibody-drug Conjugate Related to This Antibody
Full Information of The Activity Data of The ADC(s) Related to This Antibody
hD7-1 (VL-VH)-PE40 [Investigative]
Revealed Based on the Cell Line Data
Experiment 1 Reporting the Activity Date of This ADC | [1] | ||||
Efficacy Data | Half Maximal Inhibitory Concentration (IC50) |
37.00 pM
|
Positive PSMA expression (PSMA+++/++) | ||
Method Description |
The immunotoxins hD7-1 (VL-VH)-PE40 was tested for specific cytotoxic activity against PSMA-positive LNCaP and C4-2 cells.
|
||||
In Vitro Model | Lymph node metastasis of prostate carcinoma | LNCaP C4-2 cells | CVCL_4782 | ||
Experiment 2 Reporting the Activity Date of This ADC | [1] | ||||
Efficacy Data | Half Maximal Inhibitory Concentration (IC50) |
55.00 pM
|
Positive PSMA expression (PSMA+++/++) | ||
Method Description |
The immunotoxins hD7-1 (VL-VH)-PE40 was tested for specific cytotoxic activity against PSMA-positive LNCaP and C4-2 cells.
|
||||
In Vitro Model | Prostate carcinoma | LNCaP cells | CVCL_0395 |
hD7-1 (VL-VH)-PE24mut [Investigative]
Revealed Based on the Cell Line Data
Experiment 1 Reporting the Activity Date of This ADC | [1] | ||||
Efficacy Data | Half Maximal Inhibitory Concentration (IC50) |
39.00 pM
|
Positive PSMA expression (PSMA+++/++) | ||
Method Description |
The immunotoxins hD7-1 (VL-VH)-PE24mut was tested for specific cytotoxic activity against PSMA-positive LNCaP and C4-2 cells.
|
||||
In Vitro Model | Lymph node metastasis of prostate carcinoma | LNCaP C4-2 cells | CVCL_4782 | ||
Experiment 2 Reporting the Activity Date of This ADC | [1] | ||||
Efficacy Data | Half Maximal Inhibitory Concentration (IC50) |
0.18 nM
|
Positive PSMA expression (PSMA+++/++) | ||
Method Description |
The immunotoxins hD7-1 (VL-VH)-PE24mut was tested for specific cytotoxic activity against PSMA-positive LNCaP and C4-2 cells.
|
||||
In Vitro Model | Prostate carcinoma | LNCaP cells | CVCL_0395 |
hD7-1 (VL-VH)-PE24 [Investigative]
Revealed Based on the Cell Line Data
Experiment 1 Reporting the Activity Date of This ADC | [1] | ||||
Efficacy Data | Half Maximal Inhibitory Concentration (IC50) |
0.12 nM
|
Positive PSMA expression (PSMA+++/++) | ||
Method Description |
The immunotoxins hD7-1 (VL-VH)-PE24 was tested for specific cytotoxic activity against PSMA-positive LNCaP and C4-2 cells.
|
||||
In Vitro Model | Prostate carcinoma | LNCaP cells | CVCL_0395 | ||
Experiment 2 Reporting the Activity Date of This ADC | [1] | ||||
Efficacy Data | Half Maximal Inhibitory Concentration (IC50) |
0.13 nM
|
Positive PSMA expression (PSMA+++/++) | ||
Method Description |
The immunotoxins hD7-1 (VL-VH)-PE24 was tested for specific cytotoxic activity against PSMA-positive LNCaP and C4-2 cells.
|
||||
In Vitro Model | Lymph node metastasis of prostate carcinoma | LNCaP C4-2 cells | CVCL_4782 |
References
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.